Chapter 13 - The Company Nathan Left Behind
The oncology division decision returned in spring.
By then Lily was six months old.
Claire had learned to function on fractured sleep.
She had also learned how quickly boards could bury human consequences under polished presentations.
The proposed buyer renewed its offer.
Higher price.
Stronger guarantees.
Still planned to terminate the rare pediatric-cancer program.
The spin-off alternative had also improved.
Three institutional investors expressed interest.
Victor supported it.
Eleanor, though no longer a trustee, still owned personal shares and opposed it.
Claire hired two independent experts.
One recommended sale.
One recommended spin-off.
Wonderful.
No certainty.
Nathan’s notes helped.
He had spent months studying the oncology portfolio.
Claire found a memo:
Do not preserve division because Dad loved it. Preserve what works because patients need it. Sell what doesn’t.
That freed her from legacy worship.
She did not need to keep Charles’s structure intact.
She needed to evaluate current reality.
The rare-disease program was scientifically promising but expensive.
Claire visited the research team.
No media.
No speeches.
A physician-scientist named Dr. Leah Park explained the therapy.
Claire understood about sixty percent.
“So it might fail.”
“Yes.”
“Completely.”
“Yes.”
“How many patients if it works?”
“Perhaps several hundred annually in the U.S. More globally.”
Not millions.
Hundreds.
Claire thought about how corporate math could make hundreds look small.
Then Leah added:
“But for those families, the number is one.”
Claire wrote that down.
Still, sentiment was not fiduciary analysis.
Claire worked with advisers to structure the spin-off with financial discipline.
Non-core assets would be sold.
Research milestones would determine funding.
Outside investors would dilute Ashford control.
Employees would hold equity.
The plan made Eleanor furious.
“You’re giving away Charles’s company.”
Claire answered:
“I’m letting it stop being a family monument.”
The board voted.
Seven to four.
Spin-off approved.
Nathan’s shares were decisive.
Claire felt no triumph.
Only weight.
The new company was named Asteron Therapeutics.
No Ashford.
That offended half the family.
Claire liked it.
Victor declined a board seat.
Another surprise.
“I’ve had enough control.”
Thomas laughed when she told him.
“Mark the date.”
Claire’s own involvement remained limited.
She was trustee, not executive.
That distinction helped.
Then an unexpected letter arrived.
From Dr. Paul Serrano, the retired laboratory director who fabricated Jonathan Reed’s paternity report.
He had settled with Sterling and faced professional consequences.
He wrote to Claire personally.
Maya warned she owed no response.
Claire read it anyway.
Serrano described Eleanor’s pressure twelve years earlier.
He claimed Eleanor threatened to expose his unrelated billing misconduct if he refused to create the false report.
Not exoneration.
Context.
He wrote:
I told myself I was preventing a family scandal and that no one would be harmed because Charles already considered Nathan his son. I now understand I used someone else’s desired outcome to excuse falsifying evidence.
Claire recognized the pattern.
Outcome over process.
Again.
He apologized.
Claire did not reply.
She was tired of becoming the destination for other people’s conscience.
She did, however, save the letter for Lily’s future archive.
Not every apology required an answer to have meaning.
Eleanor remained mostly absent.
Then, unexpectedly, she requested to meet Lily.
Claire’s body reacted immediately.
No.
Then she stopped.
Not because Eleanor deserved access.
Because Claire wanted the decision to come from judgment, not reflex.
She consulted a therapist.
Maya.
Rachel.
Thomas.
Too many opinions.
Ultimately Claire asked herself three questions.
Was Lily physically safe?
Yes, with supervision.
Would contact undermine legal or emotional stability?
Possibly.
Did Claire want it?
Not yet.
She declined.
Eleanor responded:
I understand.
Claire stared at the message.
No threat.
No accusation.
No “you’re keeping my granddaughter from me.”
Just two words.
Maybe her lawyers wrote them.
Maybe not.
Months passed.
Eleanor sent birthday gifts through Maya.
Claire returned extravagant ones.
Kept a children’s book.
No note inside.
Thomas met Lily when she was eight months old.
He held her awkwardly.
“She looks like Nathan.”
Claire smiled.
“Everyone says that.”
“She does.”
Lily grabbed Thomas’s glasses.
He laughed.
The sound startled Claire.
Nathan used to laugh the same way when genuinely surprised.
Genetics.
Coincidence.
Memory.
Claire did not need to decide which.
Thomas looked at Lily.
“You know, technically I’m Uncle Thomas.”
“Yes.”
“Terrible branding.”
“Take it up with biology.”
He smiled.
Then became serious.
“Nathan would have been good at this.”
Claire swallowed.
“Yes.”
“He was scared.”
“Of becoming a father?”
“Of becoming Eleanor.”
Claire looked at him.
Thomas continued.
“He once told me every parent eventually discovers how easy it is to call fear love.”
Claire felt tears rise.
“He was smarter than he acted.”
“Sometimes.”
They sat quietly.
Lily fell asleep in Thomas’s arms.
A man Eleanor once hid.
Holding the granddaughter Eleanor tried to erase.
Claire felt no need to turn the image into justice.
It was simply life continuing beyond the categories Eleanor created.
Then Thomas said:
“There’s one person we haven’t talked about.”
Claire tensed.
“Please don’t say another secret sibling.”
He laughed.
“No.”
“Who?”
“Jonathan Reed.”
Claire frowned.
“The fake father.”
“Maybe.”
Thomas had been reviewing old letters Margaret left him.
One mentioned Dr. Reed.
Not as Eleanor’s lover.
As Charles’s confidant.
Thomas found the distinction strange.
Then he found another line:
Jonathan helped Charles arrange the donor.
Claire went still.
“What donor?”
Thomas looked at her.
“I don’t know.”
May you like
The paternity story, apparently, still contained one final layer.
---
